ATE516036T1 - Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten - Google Patents
Anwendung von alkylphosphocholinen in kombination mit antitumormedikamentenInfo
- Publication number
- ATE516036T1 ATE516036T1 AT03766336T AT03766336T ATE516036T1 AT E516036 T1 ATE516036 T1 AT E516036T1 AT 03766336 T AT03766336 T AT 03766336T AT 03766336 T AT03766336 T AT 03766336T AT E516036 T1 ATE516036 T1 AT E516036T1
- Authority
- AT
- Austria
- Prior art keywords
- alkylphosphocholines
- combination
- application
- antitumor drugs
- antitumor
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 229940041181 antineoplastic drug Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39961502P | 2002-07-30 | 2002-07-30 | |
| PCT/EP2003/008346 WO2004012744A1 (de) | 2002-07-30 | 2003-07-29 | Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE516036T1 true ATE516036T1 (de) | 2011-07-15 |
Family
ID=31495746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03766336T ATE516036T1 (de) | 2002-07-30 | 2003-07-29 | Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten |
Country Status (26)
| Country | Link |
|---|---|
| US (3) | US8389497B2 (enExample) |
| EP (2) | EP1545553B1 (enExample) |
| JP (1) | JP2005535688A (enExample) |
| KR (3) | KR101066804B1 (enExample) |
| CN (1) | CN1302780C (enExample) |
| AR (1) | AR040717A1 (enExample) |
| AT (1) | ATE516036T1 (enExample) |
| AU (2) | AU2003253350B2 (enExample) |
| BR (1) | BR0313048A (enExample) |
| CA (1) | CA2493023C (enExample) |
| CY (1) | CY1111902T1 (enExample) |
| DK (1) | DK1545553T3 (enExample) |
| ES (1) | ES2369535T3 (enExample) |
| HR (1) | HRP20050184B1 (enExample) |
| IL (1) | IL166329A (enExample) |
| MX (1) | MXPA05001203A (enExample) |
| NO (1) | NO335196B1 (enExample) |
| NZ (1) | NZ538428A (enExample) |
| PL (1) | PL375493A1 (enExample) |
| PT (1) | PT1545553E (enExample) |
| RU (1) | RU2005105693A (enExample) |
| SI (1) | SI1545553T1 (enExample) |
| TW (1) | TWI332007B (enExample) |
| UA (1) | UA82322C2 (enExample) |
| WO (1) | WO2004012744A1 (enExample) |
| ZA (1) | ZA200500453B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8383605B2 (en) | 2002-07-30 | 2013-02-26 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| TWI332007B (en) | 2002-07-30 | 2010-10-21 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals |
| DE10324911B4 (de) | 2003-05-30 | 2005-08-18 | Siemens Ag | Röntgenvorrichtung mit partiellem digitalem Detektor und Verfahren zum Betrieb einer solchen |
| WO2006081452A2 (en) * | 2005-01-28 | 2006-08-03 | Robert Birch | Co-administration of perifosine with chemotherapeutics |
| WO2009018233A1 (en) * | 2007-07-30 | 2009-02-05 | Ardea Biosciences, Inc. | Derivatives of n-(arylamino) sulfonamides including polymorphs as inhibitors of mek as well as compositions, methods of use and methods for preparing the same |
| JP5232009B2 (ja) * | 2005-12-19 | 2013-07-10 | エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 低減された細胞毒性を有するアルキルリン脂質誘導体並びにそれらの使用 |
| EP1800684A1 (en) * | 2005-12-20 | 2007-06-27 | Zentaris GmbH | Novel alkyl phospholipid derivatives and uses thereof |
| CN101340918B (zh) * | 2005-12-19 | 2012-10-03 | 阿特纳赞塔里斯有限公司 | 具有降低细胞毒性的新烷基磷脂衍生物及其用途 |
| US8703179B2 (en) | 2006-05-11 | 2014-04-22 | Kimberly-Clark Worldwide, Inc. | Mucosal formulation |
| MX2011006167A (es) * | 2008-12-11 | 2011-07-28 | Abraxis Bioscience Llc | Combinaciones y modos de administracion de agentes terapeuticos y terapia de combinacion. |
| MX2011011596A (es) | 2010-03-31 | 2012-02-01 | Keryx Biopharmaceuticals Inc | Perifosina y capecitabina como un tratamiento combinado para cancer. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59205998D1 (de) * | 1991-07-04 | 1996-05-23 | Asta Medica Ag | Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung |
| US5942639A (en) * | 1991-07-04 | 1999-08-24 | Asta Medica Aktiengesellschaft | Process for the preparation of alkylphosphocholines and the production thereof in pure form |
| US6172050B1 (en) * | 1992-07-11 | 2001-01-09 | Asta Medica Aktiengesellschaft | Phospholipid derivatives |
| JP3079993B2 (ja) * | 1996-03-27 | 2000-08-21 | 日本電気株式会社 | 真空マイクロデバイスおよびその製造方法 |
| DE19650778C2 (de) * | 1996-12-06 | 2001-01-04 | Asta Medica Ag | Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie |
| PL189654B1 (pl) * | 1998-01-22 | 2005-09-30 | Zentaris Gmbh | Zastosowanie miltefosyny do wytwarzania leków |
| PT1135193E (pt) * | 1998-12-04 | 2003-01-31 | Max Delbrueck Centrum | Agentes para o tratamento de tumores a base de lipossomas e compreendendo tamoxifeno |
| CA2356736A1 (en) * | 1998-12-21 | 2000-06-29 | Inkeysa. S.A. | Use of etherlysophospholipids as antiinflammatory agents |
| EP2762140B1 (en) * | 2001-02-19 | 2017-03-22 | Novartis AG | Treatment of solid brain tumours with a rapamycin derivative |
| PL365285A1 (en) * | 2001-03-23 | 2004-12-27 | Shire Biochem Inc. | Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs |
| WO2003005522A1 (es) | 2001-07-04 | 2003-01-16 | Acuna Arturo | Tapones para sellado de ductos para redes electricas, telefonicas y de fibra optica. |
| US20060084612A1 (en) * | 2002-01-02 | 2006-04-20 | Geroni Maria C | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| TWI332007B (en) | 2002-07-30 | 2010-10-21 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antitumor medicaments for the treatment of benign and malignant oncoses in humans and animals |
| WO2005000318A2 (en) * | 2003-06-23 | 2005-01-06 | Neopharm, Inc. | Method of inducing apoptosis and inhibiting cardiolipin synthesis |
| WO2006081452A2 (en) | 2005-01-28 | 2006-08-03 | Robert Birch | Co-administration of perifosine with chemotherapeutics |
| CN101340918B (zh) * | 2005-12-19 | 2012-10-03 | 阿特纳赞塔里斯有限公司 | 具有降低细胞毒性的新烷基磷脂衍生物及其用途 |
| MX2011011596A (es) * | 2010-03-31 | 2012-02-01 | Keryx Biopharmaceuticals Inc | Perifosina y capecitabina como un tratamiento combinado para cancer. |
-
2003
- 2003-07-29 TW TW092120705A patent/TWI332007B/zh not_active IP Right Cessation
- 2003-07-29 ES ES03766336T patent/ES2369535T3/es not_active Expired - Lifetime
- 2003-07-29 EP EP03766336A patent/EP1545553B1/de not_active Expired - Lifetime
- 2003-07-29 NZ NZ538428A patent/NZ538428A/en not_active IP Right Cessation
- 2003-07-29 AT AT03766336T patent/ATE516036T1/de active
- 2003-07-29 AR AR20030102710A patent/AR040717A1/es unknown
- 2003-07-29 MX MXPA05001203A patent/MXPA05001203A/es active IP Right Grant
- 2003-07-29 PT PT03766336T patent/PT1545553E/pt unknown
- 2003-07-29 CN CNB038181010A patent/CN1302780C/zh not_active Expired - Fee Related
- 2003-07-29 AU AU2003253350A patent/AU2003253350B2/en not_active Ceased
- 2003-07-29 RU RU2005105693/15A patent/RU2005105693A/ru unknown
- 2003-07-29 HR HRP20050184AA patent/HRP20050184B1/hr not_active IP Right Cessation
- 2003-07-29 JP JP2004525354A patent/JP2005535688A/ja active Pending
- 2003-07-29 KR KR1020057001510A patent/KR101066804B1/ko not_active Expired - Lifetime
- 2003-07-29 SI SI200332027T patent/SI1545553T1/sl unknown
- 2003-07-29 WO PCT/EP2003/008346 patent/WO2004012744A1/de not_active Ceased
- 2003-07-29 PL PL03375493A patent/PL375493A1/xx unknown
- 2003-07-29 KR KR1020117017914A patent/KR20110102485A/ko not_active Ceased
- 2003-07-29 UA UAA200500510A patent/UA82322C2/uk unknown
- 2003-07-29 DK DK03766336.6T patent/DK1545553T3/da active
- 2003-07-29 CA CA2493023A patent/CA2493023C/en not_active Expired - Lifetime
- 2003-07-29 BR BR0313048-7A patent/BR0313048A/pt not_active IP Right Cessation
- 2003-07-29 KR KR1020127034433A patent/KR20130016413A/ko not_active Ceased
- 2003-07-29 EP EP10010451A patent/EP2301551A1/de not_active Withdrawn
- 2003-07-30 US US10/632,187 patent/US8389497B2/en not_active Expired - Fee Related
-
2005
- 2005-01-17 IL IL166329A patent/IL166329A/en not_active IP Right Cessation
- 2005-01-18 ZA ZA2005/00453A patent/ZA200500453B/en unknown
- 2005-02-25 NO NO20051040A patent/NO335196B1/no not_active IP Right Cessation
-
2008
- 2008-07-10 AU AU2008203060A patent/AU2008203060B2/en not_active Ceased
-
2010
- 2010-03-31 US US12/751,608 patent/US8507710B2/en not_active Expired - Fee Related
- 2010-03-31 US US12/751,454 patent/US8551977B2/en not_active Expired - Fee Related
-
2011
- 2011-09-30 CY CY20111100944T patent/CY1111902T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE405310T1 (de) | Verbesserungen an antriebsmechanismen mit anwendung in verabreichungsvorrichtungen | |
| CY2018009I2 (el) | Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων | |
| DE602004004953D1 (de) | Kochfeld mit Benutzerschnittstelle und beliebiger Positionierung | |
| CY2014037I2 (el) | C-met διαμορφωτες και μεθοδοι χρησης | |
| IS7894A (is) | Skammtaform með ofnæmisvaka | |
| DE60238894D1 (de) | Beleuchtungssystem und dessen Verwendung in Projektionssystem | |
| NO20035645L (no) | Forsterket medikamentlevering i transdermale systemer | |
| DE60214640D1 (de) | Mikroprozessor mit verbesserten Taskverwaltungs- und Tabellenverwaltungsvorrichtungen | |
| CY2012024I1 (el) | Υπο-ακετυλιωμενα και υπερ-ακετυλιωμενα μηνιγγοκοκκικα καψικα σακχαριδια | |
| DE60326611D1 (de) | N und dergleichen | |
| DE602005003478D1 (de) | Mit umfaltreitern versehene zettel und fahnen | |
| EP1682989A4 (en) | SYNCHRONIZATION AND FUSION ENGINES | |
| DE60204142D1 (de) | Zubereitungen mit olopatadin zur topischen anwendung | |
| EE200200607A (et) | 2-atsüülindoolderivaadid ja nende kasutamine kasvajavastaste ravimitena | |
| DE10294402D2 (de) | Estrogen-Gestagen Kombinationspräparat und Anwendung | |
| DE60334918D1 (de) | Rotationssystem mit drei freiheitsgraden und anwendung desselben | |
| DE50213460D1 (de) | Spirocyclische 3-phenyl-3-substituierte-4-ketolaktame und -laktone | |
| ATE476500T1 (de) | Neue phospholipasen und deren verwendungen | |
| ATE516036T1 (de) | Anwendung von alkylphosphocholinen in kombination mit antitumormedikamenten | |
| EE200300473A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
| DE60225159D1 (de) | Substituierte benzimidazole und ihre anwendung in der krebsbehandlung | |
| DE602004029478D1 (de) | Echtzeit-on-line-wahrnehmung und kontrolle von emulsionen in formationsfluiden | |
| EE200300474A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
| EP1478761A4 (en) | DEGRADATION OF PESTICIDES AND HYDROPHOBIC ESTERIC TOXINS | |
| PL361518A1 (pl) | Zastosowanie substancji oraz kompozycja farmaceutyczna |